메뉴 건너뛰기




Volumn 8, Issue 3, 2014, Pages 759-762

Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver

Author keywords

Receiver operating characteristics; Threshold

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GAMMA GUANOSINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE; HIGH DENSITY LIPOPROTEIN; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 84904392876     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1798     Document Type: Article
Times cited : (19)

References (24)
  • 1
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • Chalasani N, Younossi Z, Lavine JE, et al: The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023, 2012.
    • (2012) Hepatology , vol.55 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3
  • 2
    • 84879025309 scopus 로고    scopus 로고
    • Evaluation of waist circumference cut-off values as a marker for fatty liver among Japanese workers
    • Abe N, Honda S and Jahng D: Evaluation of waist circumference cut-off values as a marker for fatty liver among Japanese workers. Saf Health Work 3: 287-293, 2012.
    • (2012) Saf Health Work , vol.3 , pp. 287-293
    • Abe, N.1    Honda, S.2    Jahng, D.3
  • 3
    • 22344452893 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    • Adams LA, Lymp JF, St Sauver J, et al: The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121, 2005.
    • (2005) Gastroenterology , vol.129 , pp. 113-121
    • Adams, L.A.1    Lymp, J.F.2    st Sauver, J.3
  • 4
    • 50649094716 scopus 로고    scopus 로고
    • Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study
    • Dunn W, Xu R, Wingard DL, et al: Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103: 2263-2271, 2008.
    • (2008) Am J Gastroenterol , vol.103 , pp. 2263-2271
    • Dunn, W.1    Xu, R.2    Wingard, D.L.3
  • 5
    • 77952730428 scopus 로고    scopus 로고
    • The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    • Ascha MS, Hanouneh IA, Lopez R, et al: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51: 1972-1978, 2010.
    • (2010) Hepatology , vol.51 , pp. 1972-1978
    • Ascha, M.S.1    Hanouneh, I.A.2    Lopez, R.3
  • 6
    • 84857984149 scopus 로고    scopus 로고
    • Dyslipidemia in patients with nonalcoholic fatty liver disease
    • Chatrath H, Vuppalanchi R and Chalasani N: Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis 32: 22-29, 2012.
    • (2012) Semin Liver Dis , vol.32 , pp. 22-29
    • Chatrath, H.1    Vuppalanchi, R.2    Chalasani, N.3
  • 7
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • Musso G, Gambino R, Cassader M and Pagano G: Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43: 617-649, 2011.
    • (2011) Ann Med , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3    Pagano, G.4
  • 8
    • 84876187637 scopus 로고    scopus 로고
    • Quantitative measurement of ultrasound attenuation and hepato-renal index in non-alcoholic fatty liver disease
    • von Volkmann HL, Havre RF, Løberg EM, et al: Quantitative measurement of ultrasound attenuation and hepato-renal index in non-alcoholic fatty liver disease. Med Ultrason 15: 16-22, 2013.
    • (2013) Med Ultrason , vol.15 , pp. 16-22
    • von Volkmann, H.L.1    Havre, R.F.2    Løberg, E.M.3
  • 9
    • 84872686317 scopus 로고    scopus 로고
    • Review article: The diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods
    • Festi D, Schiumerini R, Marzi L, et al: Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods. Aliment Pharmacol Ther 37: 392-400, 2013.
    • (2013) Aliment Pharmacol Ther , vol.37 , pp. 392-400
    • Festi, D.1    Schiumerini, R.2    Marzi, L.3
  • 10
    • 77956639983 scopus 로고    scopus 로고
    • NASH Clinical Research Network: Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease
    • Neuschwander-Tetri BA, Clark JM, Bass NM, et al; NASH Clinical Research Network: Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 52: 913-924, 2010.
    • (2010) Hepatology , vol.52 , pp. 913-924
    • Neuschwander-Tetri, B.A.1    Clark, J.M.2    Bass, N.M.3
  • 11
    • 0032718310 scopus 로고    scopus 로고
    • International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
    • Alvarez F, Berg PA, Bianchi FB, et al: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.
    • (1999) J Hepatol , vol.31 , pp. 929-938
    • Alvarez, F.1    Berg, P.A.2    Bianchi, F.B.3
  • 12
    • 67651160903 scopus 로고    scopus 로고
    • American Association for Study of Liver Diseases: Primary biliary cirrhosis
    • Lindor KD, Gershwin ME, Poupon R, et al; American Association for Study of Liver Diseases: Primary biliary cirrhosis. Hepatology 50: 291-308, 2009.
    • (2009) Hepatology , vol.50 , pp. 291-308
    • Lindor, K.D.1    Gershwin, M.E.2    Poupon, R.3
  • 13
    • 34249819694 scopus 로고    scopus 로고
    • Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits
    • Matsumoto T, Yamasaki S, Arakawa A, et al: Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits. Pathol Int 57: 388-389, 2007.
    • (2007) Pathol Int , vol.57 , pp. 388-389
    • Matsumoto, T.1    Yamasaki, S.2    Arakawa, A.3
  • 14
    • 84855651987 scopus 로고    scopus 로고
    • Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: A meta-analysis of clinical trials
    • Khan N, Abbas AM, Whang N, et al: Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials. Inflamm Bowel Dis 18: 359-367, 2012.
    • (2012) Inflamm Bowel Dis , vol.18 , pp. 359-367
    • Khan, N.1    Abbas, A.M.2    Whang, N.3
  • 15
    • 0036829092 scopus 로고    scopus 로고
    • American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease
    • Sanyal AJ; American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725, 2002.
    • (2002) Gastroenterology , vol.123 , pp. 1705-1725
    • Sanyal, A.J.1
  • 16
    • 21344449292 scopus 로고    scopus 로고
    • Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study
    • Bedogni G, Miglioli L, Masutti F, et al: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42: 44-52, 2005.
    • (2005) Hepatology , vol.42 , pp. 44-52
    • Bedogni, G.1    Miglioli, L.2    Masutti, F.3
  • 17
    • 78449286054 scopus 로고    scopus 로고
    • A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients
    • Anty R, Iannelli A, Patouraux S, et al: A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. Aliment Pharmacol Ther 32: 1315-1322, 2010.
    • (2010) Aliment Pharmacol Ther , vol.32 , pp. 1315-1322
    • Anty, R.1    Iannelli, A.2    Patouraux, S.3
  • 18
    • 84883722805 scopus 로고    scopus 로고
    • Eating a healthy lunch improves serum alanine aminotransferase activity
    • Iwamoto M, Yagi K, Yazumi K, et al: Eating a healthy lunch improves serum alanine aminotransferase activity. Lipids Health Dis 12: 134, 2013.
    • (2013) Lipids Health Dis , vol.12 , pp. 134
    • Iwamoto, M.1    Yagi, K.2    Yazumi, K.3
  • 19
    • 84865517060 scopus 로고    scopus 로고
    • Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects
    • Wu WC, Wu CY, Wang YJ, et al: Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects. Aliment Pharmacol Ther 36: 560-568, 2012.
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 560-568
    • Wu, W.C.1    Wu, C.Y.2    Wang, Y.J.3
  • 20
    • 84883759656 scopus 로고    scopus 로고
    • Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
    • Verma S, Jensen D, Hart J and Mohanty SR: Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int 33: 1398-1405, 2013.
    • (2013) Liver Int , vol.33 , pp. 1398-1405
    • Verma, S.1    Jensen, D.2    Hart, J.3    Mohanty, S.R.4
  • 21
    • 79956294683 scopus 로고    scopus 로고
    • Elevation of liver enzymes within the normal limits and metabolic syndrome
    • Xia MF, Yan HM, Lin HD, et al: Elevation of liver enzymes within the normal limits and metabolic syndrome. Clin Exp Pharmacol Physiol 38: 373-379, 2011.
    • (2011) Clin Exp Pharmacol Physiol , vol.38 , pp. 373-379
    • Xia, M.F.1    Yan, H.M.2    Lin, H.D.3
  • 22
    • 10844262508 scopus 로고    scopus 로고
    • Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups
    • Nomura K, Yano E, Shinozaki T and Tagawa K: Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups. J Occup Health 46: 423-428, 2004.
    • (2004) J Occup Health , vol.46 , pp. 423-428
    • Nomura, K.1    Yano, E.2    Shinozaki, T.3    Tagawa, K.4
  • 23
    • 84869166012 scopus 로고    scopus 로고
    • Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units
    • Hu X, Huang Y, Bao Z, et al: Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol 12: 123, 2012.
    • (2012) BMC Gastroenterol , vol.12 , pp. 123
    • Hu, X.1    Huang, Y.2    Bao, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.